The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements
Crossref DOI link: https://doi.org/10.1007/s40258-016-0274-x
Published Online: 2016-08-31
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toumi, Mondher http://orcid.org/0000-0001-7939-7204
Jarosławski, Szymon
Sawada, Toyohiro
Kornfeld, Åsa
License valid from 2016-08-31